Scan to Download
One power score. Smarter investment decisions
Nuvectis Pharma Inc
NVCT6.270USD
-0.130-2.03%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
149.71MMarket Cap
LossP/E TTM
Nuvectis Pharma Inc
6.270
-0.130-2.03%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
Operating expenses
42.04%6.59M
26.66%5.57M
-6.07%6.45M
-29.21%4.36M
-19.56%4.64M
7.19%4.40M
1.30%6.87M
3.70%6.16M
61.54%5.77M
39.25%4.10M
--6.78M
--5.94M
--3.57M
--2.94M
R&D expenses
22.77%3.61M
38.35%3.68M
-7.45%4.50M
-37.16%2.82M
-30.95%2.94M
12.38%2.66M
10.48%4.86M
-0.75%4.49M
70.14%4.26M
31.14%2.37M
--4.40M
--4.52M
--2.50M
--1.81M
Depreciation, depletion, and amortization
--0.00
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
----
--0.00
--0.00
--0.00
Other operating expenses
----
----
----
----
----
----
---593.00K
----
----
----
----
----
----
----
Operating profit
-42.04%-6.59M
-26.66%-5.57M
6.07%-6.45M
29.21%-4.36M
19.56%-4.64M
-7.19%-4.40M
-1.30%-6.87M
-3.70%-6.16M
-61.54%-5.77M
-39.25%-4.10M
---6.78M
---5.94M
---3.57M
---2.94M
Net non-operating interest income (expenses)
Non-operating interest income
21.40%261.00K
4.89%236.00K
-17.62%201.00K
-25.63%206.00K
235.94%215.00K
332.69%225.00K
197.56%244.00K
354.10%277.00K
1500.00%64.00K
2500.00%52.00K
--82.00K
--61.00K
--4.00K
--2.00K
Income before tax
-43.04%-6.33M
-27.84%-5.33M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
---6.70M
---5.88M
---3.57M
---2.94M
Income after tax
-43.04%-6.33M
-27.84%-5.33M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
---6.70M
---5.88M
---3.57M
---2.94M
Net income from continuous operations
-43.04%-6.33M
-27.84%-5.33M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
---6.70M
---5.88M
---3.57M
---2.94M
Net income attributable to controlling interests
-43.04%-6.33M
-27.84%-5.33M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
---6.70M
---5.88M
---3.57M
---2.94M
Net income attributable to common shareholders
-43.04%-6.33M
-27.84%-5.33M
5.65%-6.25M
29.38%-4.15M
22.42%-4.43M
-3.01%-4.17M
1.11%-6.62M
-0.07%-5.88M
-59.93%-5.71M
-37.58%-4.05M
---6.70M
---5.88M
---3.57M
---2.94M
Basic earnings per share
-13.15%-0.30
-6.18%-0.27
13.92%-0.35
34.00%-0.24
30.33%-0.26
8.40%-0.25
10.49%-0.41
12.69%-0.37
-34.01%-0.38
14.42%-0.27
---0.46
---0.42
---0.28
---0.32
Diluted earnings per share
-13.15%-0.30
-6.18%-0.27
13.92%-0.35
34.00%-0.24
30.33%-0.26
8.40%-0.25
10.49%-0.41
12.69%-0.37
-34.01%-0.38
14.42%-0.27
---0.46
---0.42
---0.28
---0.32
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
